Genmab — Juni 2017

[JohnW]

Interesting month E L. Will Genmab have presentations at all these events?

[E_L]

yes

[JohnW]

I guess their presentation will be the same for all these events. But the audience might be different?

[Nickstar]

Er det 15/6 der kommer salgstal?

[Raffles]

Regarding the presentations I believe we should also mention JnJ participate in Jefferies 2017 conference on june 8th. Trust DARA will be mentioned:-)

[jkj]

3 onsdag i hver mrd.

[E_L]

Sure, these banks will invite their customers. But the bigger ones will deal with all these banks anyway

[E_L]

thks Raffles

[Nickstar]

Tak JKJ

[Joakim_Von_And]

Hvad hedder næste gap der skal lukkes??

[Solsen]

ha - vi er i sell on facts mode og kan komme godt ned, tror jeg.

[Solsen]

Who cares

[Joakim_Von_And]

1350??

[Solsen]

Måske

[kkjoel]

@Nickstar: Salgstallene fra Syphony Health kommer 2. onsdag efter 2. lørdag hver måned.
Mærkeligt regel, men sådan er det.

[Legolas23]

Det kunne også være et sell-out for at presse private invetstorer ud inden godkendelse i 3. linie og salgstal. For mig ligner det et spekulativt salg af de anonyme for at køre andre private over
.

[BobTheThird]

Helt enig Legolas. Ville heller ikke være overrasket hvis den vender endnu engang ved udangen af i dag.

[Nickstar]

Ah, så forstår jeg.
tak Kkjoel

[Helge_LarsenPI-redaktør]

Sydbank på Play: https://play.borsen.dk/social/5934ee2c45628ff817205648

[kkjoel]

Danske Bank: "6 June 2017 / Investment cases and follow-ups / Genmab (Buy) / Daratumumab has been presented at ASCO with encouraging cytogenetic risk data and solid DKRd NDMM data; but inconclusive vs historical KRd ORR rates. The POLLUX PFS continues its strong trend to support long-term maintenance use. We keep our Buy rating and DKK1,670 per share 12-month target price."